{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T15:07:22Z","timestamp":1761491242778,"version":"3.41.0"},"reference-count":40,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,8]]},"abstract":"<jats:p>Interleukin (IL)-7 plays a vital role in proliferation and activation of T cells, however, its signaling through CD127 is impaired in T cells in cancers and chronic infections. The mechanisms underlying T helper 17 (Th17) cell responses by IL-7 in melanoma remain not fully understood. The aim of this study was to assess the effect of IL-7 signaling on Th17 responses in patients with primary cutaneous melanoma. Healthy and primary cutaneous melanoma donors were selected for this study of Th17 cell function. IL-17<jats:sup>+<\/jats:sup>CD4<jats:sup>+<\/jats:sup> Th17 cells and CD127 expression on Th17 cells were determined by flow cytometry. Cytokine level was measured by ELISA. Peripheral and tissue-infiltrating CD4<jats:sup>+<\/jats:sup> T cells were isolated using magnetic beads, and then stimulated with IL-7 and\/or signal transducer and activator of transcription 5 inhibitor. Activated signaling molecules were analyzed by flow cytometry. Peripheral and tumor-infiltrating Th17 cells percentage was decreased, while peripheral IL-7 level was also reduced in melanoma patients. There was no significant difference of CD127 expression on Th17 cells between melanoma patients and controls. Antiapoptotic protein Bcl-2 was downregulated, whereas proapoptotic protein-activated caspase-3 was upregulated in peripheral and tissue-infiltrating Th17 cells in melanoma patients. Higher concentration of IL-7 (10 ng\/mL), but not lower IL-7 concentration (1 ng\/mL), promoted Bcl-2 expression and decreased caspase-3 expression in Th17 cells in melanoma patients. Inhibition of signal transducer and activator of transcription 5 resulted in the downregulation of Bcl-2 while upregulation of caspase-3 in Th17 cells. The present data suggested that reduced IL-7 responsiveness might be insufficient for Th17 activation in patients with primary cutaneous melanoma.<\/jats:p>","DOI":"10.1097\/cmr.0000000000000751","type":"journal-article","created":{"date-parts":[[2021,5,31]],"date-time":"2021-05-31T01:03:19Z","timestamp":1622422999000},"page":"328-337","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":6,"title":["Induction of T helper 17 cell response by interleukin-7 in patients with primary cutaneous melanoma"],"prefix":"10.1097","volume":"31","author":[{"given":"Hongxia","family":"He","sequence":"first","affiliation":[{"name":"Department of Dermatology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Binjun","family":"Qiao","sequence":"additional","affiliation":[{"name":"Department of Emergency"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuping","family":"Guo","sequence":"additional","affiliation":[{"name":"Department of Dermatology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongzhou","family":"Cui","sequence":"additional","affiliation":[{"name":"Department of Dermatology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ning","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Pathology, The First Hospital of Shanxi Medical University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongye","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Dermatology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junxia","family":"Qin","sequence":"additional","affiliation":[{"name":"Department of Dermatology, The Affiliated Shanxi Provincial People\u2019s Hospital of Shanxi Medical University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinghong","family":"He","sequence":"additional","affiliation":[{"name":"Department of Radiology, The First Hospital of Shanxi Medical University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaofeng","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Dermatology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenli","family":"Xue","sequence":"additional","affiliation":[{"name":"Department of Dermatology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanzhen","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Rehabilitation, Children\u2019s Hospital of Shanxi Province, Taiyuan, Shanxi Province, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2021,5,28]]},"reference":[{"key":"R1-20250528","first-page":"132","article-title":"Controversies in the diagnosis and treatment of early cutaneous melanoma.","volume":"8","author":"Orzan","year":"2015","journal-title":"J Med Life"},{"key":"R2-20250528","first-page":"1005","article-title":"Melanoma: epidemiology, risk factors, pathogenesis, diagnosis and classification.","volume":"28","author":"Rastrelli","year":"2014","journal-title":"In Vivo"},{"key":"R3-20250528","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1067\/j.cpsurg.2013.04.001","article-title":"Current management of melanoma.","volume":"50","author":"Dunki-Jacobs","year":"2013","journal-title":"Curr Probl Surg"},{"key":"R4-20250528","doi-asserted-by":"crossref","first-page":"446e","DOI":"10.1097\/PRS.0b013e31829ad411","article-title":"Managing malignant melanoma.","volume":"132","author":"Dzwierzynski","year":"2013","journal-title":"Plast Reconstr Surg"},{"key":"R5-20250528","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.det.2019.06.001","article-title":"Update on current treatment recommendations for primary cutaneous melanoma.","volume":"37","author":"Dowling","year":"2019","journal-title":"Dermatol Clin"},{"key":"R6-20250528","doi-asserted-by":"crossref","first-page":"1608132","DOI":"10.1080\/2162402X.2019.1608132","article-title":"The new identified biomarkers determine sensitivity to immune check-point blockade therapies in melanoma.","volume":"8","author":"Chen","year":"2019","journal-title":"Oncoimmunology"},{"key":"R7-20250528","doi-asserted-by":"crossref","first-page":"119","DOI":"10.3389\/fmed.2019.00119","article-title":"Biomarkers for immune checkpoint inhibitor-mediated tumor response and adverse events.","volume":"6","author":"Nakamura","year":"2019","journal-title":"Front Med (Lausanne)"},{"key":"R8-20250528","doi-asserted-by":"crossref","first-page":"963","DOI":"10.21873\/anticanres.11405","article-title":"The role of IL-7 in immunity and cancer.","volume":"37","author":"Lin","year":"2017","journal-title":"Anticancer Res"},{"key":"R9-20250528","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1038\/s41590-019-0479-x","article-title":"Flip the coin: IL-7 and IL-7R in health and disease.","volume":"20","author":"Barata","year":"2019","journal-title":"Nat Immunol"},{"key":"R10-20250528","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.jbior.2018.09.012","article-title":"IL-7R-mediated signaling in T-cell acute lymphoblastic leukemia: An update.","volume":"71","author":"Oliveira","year":"2019","journal-title":"Adv Biol Regul"},{"key":"R11-20250528","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1189\/jlb.0313122","article-title":"Jak\/STAT and PI3K signaling pathways have both common and distinct roles in IL-7-mediated activities in human CD8+ T cells.","volume":"95","author":"Crawley","year":"2014","journal-title":"J Leukoc Biol"},{"key":"R12-20250528","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1111\/j.1365-2567.2009.03244.x","article-title":"Interleukin-7 promotes the survival of human CD4+ effector\/memory T cells by up-regulating Bcl-2 proteins and activating the JAK\/STAT signalling pathway.","volume":"130","author":"Chetoui","year":"2010","journal-title":"Immunology"},{"key":"R13-20250528","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1111\/1523-1747.ep12382320","article-title":"Interleukin-7 induces differential lymphokine-activated killer cell activity against human melanoma cells, keratinocytes, and endothelial cells.","volume":"102","author":"Schadendorf","year":"1994","journal-title":"J Invest Dermatol"},{"key":"R14-20250528","doi-asserted-by":"crossref","first-page":"3686","DOI":"10.1182\/blood.V82.12.3686.3686","article-title":"Transduction of human melanoma cell lines with the human interleukin-7 gene using retroviral-mediated gene transfer: comparison of immunologic properties with interleukin-2.","volume":"82","author":"Miller","year":"1993","journal-title":"Blood"},{"key":"R15-20250528","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1097\/QAD.0000000000002164","article-title":"IL-7-induced proliferation of peripheral Th17 cells is impaired in HAART-controlled HIV infection.","volume":"33","author":"C\u00f4t\u00e9","year":"2019","journal-title":"AIDS"},{"key":"R16-20250528","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.cyto.2017.12.014","article-title":"Interleukin-7 augments CD8+ T cells function and promotes viral clearance in chronic hepatitis C virus infection.","volume":"102","author":"Hou","year":"2018","journal-title":"Cytokine"},{"key":"R17-20250528","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.cyto.2018.04.003","article-title":"Interleukin-7 enhances anti-tumor activity of CD8+ T cells in patients with hepatocellular carcinoma.","volume":"118","author":"Teng","year":"2019","journal-title":"Cytokine"},{"key":"R18-20250528","doi-asserted-by":"crossref","first-page":"730380","DOI":"10.1155\/2014\/730380","article-title":"The Treg\/Th17 paradigm in lung cancer.","volume":"2014","author":"Duan","year":"2014","journal-title":"J Immunol Res"},{"key":"R19-20250528","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1080\/14728222.2016.1206891","article-title":"The IL-17-Th1\/Th17 pathway: an attractive target for lung cancer therapy?.","volume":"20","author":"Joerger","year":"2016","journal-title":"Expert Opin Ther Targets"},{"key":"R20-20250528","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1016\/j.jhep.2008.12.033","article-title":"Increased intratumoral IL-17-producing cells correlate with poor survival in hepatocellular carcinoma patients.","volume":"50","author":"Zhang","year":"2009","journal-title":"J Hepatol"},{"key":"R21-20250528","first-page":"326","article-title":"The association between peripheral Th17, Th1, IL-17, and IFN-\u03b3 levels and TACE response in patients with unresectable hepatocellular carcinoma with or without cirrhosis.","volume":"52","author":"Hasan","year":"2020","journal-title":"Acta Med Indones"},{"key":"R22-20250528","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/s12013-011-9276-3","article-title":"Expression of Th17 cells in breast cancer tissue and its association with clinical parameters.","volume":"62","author":"Yang","year":"2012","journal-title":"Cell Biochem Biophys"},{"key":"R23-20250528","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1158\/0008-5472.CAN-10-2907","article-title":"Clinical impact of different classes of infiltrating T cytotoxic and helper cells (Th1, th2, treg, th17) in patients with colorectal cancer.","volume":"71","author":"Tosolini","year":"2011","journal-title":"Cancer Res"},{"key":"R24-20250528","doi-asserted-by":"crossref","first-page":"7424","DOI":"10.3390\/ijms12117424","article-title":"Distribution and clinical significance of Th17 cells in the tumor microenvironment and peripheral blood of pancreatic cancer patients.","volume":"12","author":"He","year":"2011","journal-title":"Int J Mol Sci"},{"key":"R25-20250528","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1007\/s12272-019-01146-9","article-title":"T helper 17 (Th17) cells and interleukin-17 (IL-17) in cancer.","volume":"42","author":"Chang","year":"2019","journal-title":"Arch Pharm Res"},{"key":"R26-20250528","first-page":"1368","article-title":"TH17 is involved in the remarkable regression of metastatic malignant melanoma to topical diphencyprone.","volume":"9","author":"Martiniuk","year":"2010","journal-title":"J Drugs Dermatol"},{"key":"R27-20250528","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1182\/blood-2007-11-120998","article-title":"Tumor-specific Th17-polarized cells eradicate large established melanoma.","volume":"112","author":"Muranski","year":"2008","journal-title":"Blood"},{"key":"R28-20250528","doi-asserted-by":"crossref","first-page":"187","DOI":"10.3389\/fimmu.2019.00187","article-title":"Th17 cells paradoxical roles in melanoma and potential application in immunotherapy.","volume":"10","author":"Chen","year":"2019","journal-title":"Front Immunol"},{"key":"R29-20250528","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1097\/CJI.0b013e318247a4e7","article-title":"PD-1 blockade augments Th1 and Th17 and suppresses Th2 responses in peripheral blood from patients with prostate and advanced melanoma cancer.","volume":"35","author":"Dulos","year":"2012","journal-title":"J Immunother"},{"key":"R30-20250528","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/1479-5876-7-35","article-title":"CTLA4 blockade increases Th17 cells in patients with metastatic melanoma.","volume":"7","author":"von Euw","year":"2009","journal-title":"J Transl Med"},{"key":"R31-20250528","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.intimp.2018.12.022","article-title":"Interleukin-7 promotes lung-resident CD14+ monocytes activity in patients with lung squamous carcinoma.","volume":"67","author":"Li","year":"2019","journal-title":"Int Immunopharmacol"},{"key":"R32-20250528","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1089\/vim.2018.0010","article-title":"Interleukin-7 regulates T follicular helper cell function in patients with chronic hepatitis C.","volume":"31","author":"Zhang","year":"2018","journal-title":"Viral Immunol"},{"key":"R33-20250528","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.cell.2011.01.011","article-title":"IL-7 engages multiple mechanisms to overcome chronic viral infection and limit organ pathology.","volume":"144","author":"Pellegrini","year":"2011","journal-title":"Cell"},{"key":"R34-20250528","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.cell.2011.01.038","article-title":"IL-7 knocks the socs off chronic viral infection.","volume":"144","author":"Parish","year":"2011","journal-title":"Cell"},{"key":"R35-20250528","doi-asserted-by":"crossref","first-page":"11155","DOI":"10.1038\/s41598-017-11492-7","article-title":"IL-7 plays a critical role for the homeostasis of allergen-specific memory CD4 T cells in the lung and airways.","volume":"7","author":"Yeon","year":"2017","journal-title":"Sci Rep"},{"key":"R36-20250528","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.3892\/mmr.2020.11191","article-title":"Effect of IL-7 on Th17 cell responses in a mouse model of neutrophilic asthma.","volume":"22","author":"Zhang","year":"2020","journal-title":"Mol Med Rep"},{"key":"R37-20250528","doi-asserted-by":"crossref","first-page":"5459","DOI":"10.1093\/emboj\/cdg533","article-title":"Bcl-xL\/Bcl-2 coordinately regulates apoptosis, cell cycle arrest and cell cycle entry.","volume":"22","author":"Janumyan","year":"2003","journal-title":"EMBO J"},{"key":"R38-20250528","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1634\/stemcells.20-4-355","article-title":"The molecular perspective: Bcl-2 and apoptosis.","volume":"20","author":"Goodsell","year":"2002","journal-title":"Stem Cells"},{"key":"R39-20250528","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/978-3-030-55617-4_2","article-title":"Interleukin (IL)-7 signaling in the tumor microenvironment.","volume":"1290","author":"Bednarz-Misa","year":"2021","journal-title":"Adv Exp Med Biol"},{"key":"R40-20250528","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.3892\/ol.2020.11706","article-title":"Mechanisms of JAK-STAT signaling pathway mediated by CXCL8 gene silencing on epithelial-mesenchymal transition of human cutaneous melanoma cells.","volume":"20","author":"Hu","year":"2020","journal-title":"Oncol Lett"}],"container-title":["Melanoma Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/CMR.0000000000000751","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,28]],"date-time":"2025-05-28T21:46:10Z","timestamp":1748468770000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/CMR.0000000000000751"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,28]]},"references-count":40,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/cmr.0000000000000751","relation":{},"ISSN":["0960-8931"],"issn-type":[{"type":"print","value":"0960-8931"}],"subject":[],"published":{"date-parts":[[2021,5,28]]}}}